Atlantic Edge Private Wealth Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
SRIM
SAM
GA
AIIMS
QI
AA
GIM
CFB
Atlantic Edge Private Wealth Management's NVO Position: Q2 2026 in Review
Atlantic Edge Private Wealth Management held its Novo Nordisk (NVO) position steady in Q2 2026 at 275 shares worth $13.2K. The position accounts for ﹤0.01% of the portfolio, ranked #389.
Atlantic Edge Private Wealth Management first reported a position in NVO in Q4 2023 and has held it in 11 quarters since. The position peaked at $46.4K in Q2 2024. 549 funds tracked by Wall St. Rank hold NVO as of Q2 2026.
- Atlantic Edge Private Wealth Management held 275 shares of Novo Nordisk worth $13.2K as of Q2 2026.
- Atlantic Edge Private Wealth Management left its Novo Nordisk share count unchanged in Q2 2026.
- Novo Nordisk made up ﹤0.01% of Atlantic Edge Private Wealth Management's portfolio in Q2 2026, its #389 holding.
- Atlantic Edge Private Wealth Management first reported a position in Novo Nordisk in Q4 2023 and has held it in 11 quarters since.
- Atlantic Edge Private Wealth Management's Novo Nordisk position peaked at $46.4K in Q2 2024.
- 549 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.
Based on Atlantic Edge Private Wealth Management's 13F filing for Q2 2026, filed 23 Jul 2026.